At its simplest, biotechnology is technology based on biology - biotechnology harnesses cellular and biomolecular processes to develop technologies and products that help improve our lives and the ...

In September 2025, the U.S. FDA launched a major enforcement campaign targeting direct-to-consumer (DTC) pharmaceutical advertising that misleads patients or downplays risks. Following a September ...

Jane Xia is an Assistant General Counsel Patents at Johnson & Johnson, specializing in patent strategy, portfolio development, licensing, and IP-related transactions. With over 13 years of experience, ...

Patient advocates say transparency will help the 340B program realign with its original intent of helping patients. Also, thoughts on supporting small molecules achieving big results. (735 words, 3 ...

How can smart policy secure America’s leadership in biotechnology? BIO President & CEO John F. Crowley outlined the path forward in Senate testimony and a joint op-ed with Sen. Todd Young (R-IN). (703 ...

BIO seeks dynamic, professional candidates with industry expertise and knowledge for our open positions. If you're interested in joining our team, please see the links below to view our current ...

Meetings between the Food and Drug Administration (FDA) and industry sponsors are critical to conducting effective and efficient drug development and bringing life-changing, innovative medicines to ...

Dr. Carlos A. Garcia serves as Director and Senior Counsel – Intellectual Property & Litigation at Amgen Inc., with over 13 years of experience in global patent strategy, prosecution, and litigation ...

•The FDA is undergoing a strategic reevaluation of its policies under new leadership, prompted by rapid advancements in science and technology. •Now is the time for FDA to pursue a proactive policy ...

Theodore is an intellectual Property attorney with 20+ years of experience protecting innovation and building patent portfolios, including preparing and executing strategic intellectual property plans ...

Rachel leads intellectual property and licensing at Arc. Previously, she held patent prosecution and licensing roles at both law firms and biotechnology companies. Rachel received a J.D. from Santa ...

Don Ware, a Partner at Foley Hoag, has over 40 years’ experience representing leading biopharma manufacturers, research institutions, and universities in patent and inventorship disputes, licensing, ...